ALLG
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Allego receives a Neutral rating with a composite score of 42.8, placing it in the middle range of expectations. With a conviction level of 2 out of 5, Allego demonstrates balanced strengths and challenges. The fundamentals pillar is noteworthy for its alignment, despite reporting reduced revenue growth and negative operating margins, indicating structural profitability issues. Regulatory stability contributes positively, albeit with some areas lacking momentum. The market pillar lags due to insufficient available performance data and editorial presence remains minimal, as no significant company coverage or briefings have materialized recently.
Despite robust market capitalization positioning, the company suffers from a significant drop in year-over-year revenue and poor gross margins, leading to a notable net income deficit. Allego's negative EBITDA further highlights operational inefficiencies. Regulatory insight shows a lack of significant jurisdictional events and filing cadence irregularities. However, enforcement metrics exhibit resilience, with no infractions impacting the company adversely. The overall financial condition of Allego is stretched, with cash conservation efforts evident but balanced against ongoing high cash burn.
Moving forward, Allego's most viable pathway for enhancement within the Neutral band lies with strengthening its regulatory footing. The absence of recent jurisdictional events alongside sound enforcement practices indicates a solid foundation ripe for development. By increasing transparency and improving filing cadence, Allego could potentially leverage its regulatory environment to drive a stabilization of fundamentals, providing a clearer runway for steady growth amid operational and market challenges.
- IR / PR agency
- ICR, LLC
- IR email
- investors@allego.eu
- IR page
- Investor relations
- CEO
- Mathieu Bonnet
- CFO
- Steven Salo
- SEC CIK
- 0001874474
- Website
- Company website
- Market cap
- $496.9M
- Enterprise value
- $939.6M
- Price to book
- 10.94
- Price to sales
- 3.42
- EV / EBITDA
- -6.62
- Revenue (TTM)
- $145.5M
- Gross profit (TTM)
- $25.2M
- EBITDA
- $-43.1M
- Operating margin
- -25.1%
- Profit margin
- -75.6%
- Rev growth YoY
- -20.1%
- Return on equity
- -760.3%
- Return on assets
- -8.7%
- EPS (TTM)
- $-0.46
- Wall St. target price
- $7.50
- Shares outstanding
- 273.0M
- Insider ownership
- 4.9%
- Institutional ownership
- 95.6%
- Beta
- 0.76
- Full-time employees
- 190
- GICS sector
- Consumer Cyclical
- GICS industry
- Specialty Retail
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for ALLG (ALLG)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for ALLG (ALLG), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for ALLG are maintained by Cannabis Investor News and refreshed throughout the trading day.